Lynch JP - Search Results

1

High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic model.

Qazilbash MH, Devetten MP, Abraham J, Lynch JP, Beall CL, Auber M, Weisenborn R, Bunner P, Ericson SG. Qazilbash MH, et al. Among authors: lynch jp. Acta Haematol. 2003;110(4):173-8. doi: 10.1159/000074220. Acta Haematol. 2003. PMID: 14663160

2

Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.

Kurian S, Qazilbash M, Fay J, Wolff S, Herzig R, Hobbs G, Bunner P, Weisenborn R, Aya-Ay M, Lynch J, Ericson S. Kurian S, et al. Breast J. 2006 Nov-Dec;12(6):531-5. doi: 10.1111/j.1524-4741.2006.00341.x. Breast J. 2006. PMID: 17238982 Clinical Trial.

3

Utility of a prognostic scoring system for allogeneic stem cell transplantation in patients with chronic myeloid leukemia.

Qazilbash MH, Devetten MP, Abraham J, Lynch JP, Beall CL, Weisenborn R, Bunner P, Ericson SG. Qazilbash MH, et al. Among authors: lynch jp. Acta Haematol. 2003;109(3):119-23. doi: 10.1159/000069283. Acta Haematol. 2003. PMID: 12714820

4

Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial.

Devetten MP, Qazilbash MH, Beall CL, Bunner P, Weisenborn R, Lynch JP, Ericson SG. Devetten MP, et al. Among authors: lynch jp. Bone Marrow Transplant. 2004 Oct;34(7):577-80. doi: 10.1038/sj.bmt.1704642. Bone Marrow Transplant. 2004. PMID: 15286685 Clinical Trial.

5

Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.

Wolff SN, Herzig R, Lynch J, Ericson SG, Greer JP, Stein R, Goodman S, Benyunes MC, Ashby M, Jones DV Jr, Fay J. Wolff SN, et al. Among authors: lynch j. Bone Marrow Transplant. 2001 Feb;27(3):261-8. doi: 10.1038/sj.bmt.1702772. Bone Marrow Transplant. 2001. PMID: 11277173 Clinical Trial.

6

Disruption of bone marrow stromal cell function by etoposide.

Gibson LF, Fortney J, Landreth KS, Piktel D, Ericson SG, Lynch JP. Gibson LF, et al. Among authors: lynch jp. Biol Blood Marrow Transplant. 1997 Aug;3(3):122-32. Biol Blood Marrow Transplant. 1997. PMID: 9310189

7

Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.

Gibson LF, Fortney J, Magro G, Ericson SG, Lynch JP, Landreth KS. Gibson LF, et al. Among authors: lynch jp. Breast Cancer Res Treat. 1999 May;55(2):107-17. doi: 10.1023/a:1006175811676. Breast Cancer Res Treat. 1999. PMID: 10481938

8

Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.

Higa GM, DeVore RF, Auber ML, Lynch JP, Landreth KS. Higa GM, et al. Among authors: lynch jp. Pharmacotherapy. 1998 Jan-Feb;18(1):1-8. Pharmacotherapy. 1998. PMID: 9469674 Clinical Trial.

9

Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor.

Ericson SG, Zhao Y, Gao H, Miller KL, Gibson LF, Lynch JP, Landreth KS. Ericson SG, et al. Among authors: lynch jp. Blood. 1998 Mar 15;91(6):2099-107. Blood. 1998. PMID: 9490696 Free article.

10

'False-positive' pregnancy tests pretransplant.

Ericson SG, Gnegy S, Auber M, Beall CL, Andria ML, Lynch JP. Ericson SG, et al. Among authors: lynch jp. Bone Marrow Transplant. 1997 Oct;20(8):709. doi: 10.1038/sj.bmt.1700951. Bone Marrow Transplant. 1997. PMID: 9383239 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters